Literature DB >> 24859878

Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma.

Fatima Hamadeh1, Stephen MacNamara1, Chris M Bacon2, Aliyah R Sohani3, Steven H Swerdlow4, James R Cook5.   

Abstract

Entities:  

Keywords:  MYD88 L265P; gamma heavy chain disease; lymphoplasmacytic lymphoma; mutation

Mesh：

Substances：

Year:  2014        PMID： 24859878      PMCID： PMC4562547          DOI： 10.3324/haematol.2014.108688

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.

Authors:  J A Andriko; S H Swerdlow; N I Aguilera; S L Abbondanzo
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

2.  Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.

Authors:  Shannon Bieliauskas; Raymond R Tubbs; Chris M Bacon; Camellia Eshoa; Kathryn Foucar; Sarah E Gibson; Steven H Kroft; Aliyah R Sohani; Steven H Swerdlow; James R Cook
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

3.  Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy.

Authors:  Nikhil C Munshi; Subba Digumarthy; Aliyah Rahemtullah
Journal:  N Engl J Med       Date:  2008-04-24       Impact factor: 91.245

4.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Authors:  Steven P Treon; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Patricia Sheehy; Robert J Manning; Christopher J Patterson; Christina Tripsas; Luca Arcaini; Geraldine S Pinkus; Scott J Rodig; Aliyah R Sohani; Nancy Lee Harris; Jason M Laramie; Donald A Skifter; Stephen E Lincoln; Zachary R Hunter
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

Review 5.  Heavy chain diseases.

Authors:  Dietlind L Wahner-Roedler; Robert A Kyle
Journal:  Best Pract Res Clin Haematol       Date:  2005       Impact factor: 3.020

6.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Authors:  Lian Xu; Zachary R Hunter; Guang Yang; Yangsheng Zhou; Yang Cao; Xia Liu; Enrica Morra; Alessandra Trojani; Antonino Greco; Luca Arcaini; Marzia Varettoni; Maria Varettoni; Jennifer R Brown; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi; Christopher J Patterson; Robert J Manning; Christina K Tripsas; Neal I Lindeman; Steven P Treon
Journal:  Blood       Date:  2013-01-15       Impact factor: 22.113

7.  MYD88 L265P mutation in Waldenstrom macroglobulinemia.

Authors:  Stéphanie Poulain; Christophe Roumier; Audrey Decambron; Aline Renneville; Charles Herbaux; Elisabeth Bertrand; Sabine Tricot; Agnès Daudignon; Sylvie Galiègue-Zouitina; Valerie Soenen; Olivier Theisen; Nathalie Grardel; Olivier Nibourel; Catherine Roche-Lestienne; Bruno Quesnel; Patrick Duthilleul; Claude Preudhomme; Xavier Leleu
Journal:  Blood       Date:  2013-03-26       Impact factor: 22.113

8.  Gamma-heavy chain disease: review of 23 cases.

Authors:  Dietlind L Wahner-Roedler; Thomas E Witzig; Laura L Loehrer; Robert A Kyle
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

9.  Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).

Authors:  James R Cook; Nadine Ives Aguilera; Shalini Reshmi-Skarja; Xin Huang; Zhisheng Yu; Susanne M Gollin; Susan L Abbondanzo; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2004-04       Impact factor: 3.466

10.  IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.

Authors:  N Gachard; M Parrens; I Soubeyran; B Petit; A Marfak; D Rizzo; M Devesa; M Delage-Corre; V Coste; M P Laforêt; A de Mascarel; J P Merlio; K Bouabdhalla; N Milpied; P Soubeyran; A Schmitt; D Bordessoule; M Cogné; J Feuillard
Journal:  Leukemia       Date:  2012-09-04       Impact factor: 11.528
View more
  3 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

2.  MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors:  Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

Review 3.  The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.

Authors:  Steven H Swerdlow; Isinsu Kuzu; Ahmet Dogan; Stephan Dirnhofer; John K C Chan; Birgitta Sander; German Ott; Luc Xerri; Leticia Quintanilla-Martinez; Elias Campo
Journal:  Virchows Arch       Date:  2015-10-10       Impact factor: 4.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.